ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Actavis Acquires Indian Drug Facility

January 8, 2007 | APPEARED IN VOLUME 85, ISSUE 2

Icelandic generic drugmaker Actavis has bought a manufacturing plant in Alathur, India, from the Indian firm Grandix Pharmaceuticals. The site manufactures solid oral dosage formulations of drugs. Actavis notes that it recently opened an active pharmaceutical ingredient development facility in India, and in 2005 it acquired Lotus Laboratories, a Bangalore-based contract research organization.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment